Decheng Capital Global Life Sciences Fund IV, L.P.
CIK 0001834150
10% Owner
Filings
3
Latest Feb 19, 2025
Issuers covered
2
Showing
3 of 3
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 50% | -5.2% | -5.2% | +20.0% | -30.4% |
| 90 days | 4 | 50% | -7.3% | -7.3% | +17.1% | -31.7% |
| 180 days | 4 | 0% | -15.6% | -15.6% | -15.3% | -15.8% |
| 365 days | 4 | 0% | -12.3% | -12.3% | -6.4% | -18.1% |
Issuers
Companies where Decheng Capital Global Life Sciences Fund IV, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CGON | Cg Oncology, Inc. | 2 | Apr 9, 2024 |
| AARD | Aardvark Therapeutics, Inc. | 1 | Feb 19, 2025 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|